🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with mash resolution without worsening fibrosis? Page 4

Has anyone dealt with mash resolution without worsening fibrosis?

KevinCompounds Thu, Oct 31, 2024 at 11:40 AM 45 replies 2,606 viewsPage 4 of 9
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Oct 31, 2024 at 5:20 PM#16

Congrats mia_MS2!! You should be so proud of yourself. 🎉

14 1RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 11 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Oct 31, 2024 at 5:37 PM#17

KevinCompounds's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I am on a different medication. But the overall trajectory has been remarkably similar. Down 63 lbs in 8 months.

One thing I would add that KevinCompounds did not mention: my sleep quality improved dramatically.

36 6LibrarianMeg, bri_stats, pete_manc_UK and 33 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Oct 31, 2024 at 5:54 PM#18

Bookmarked 📌 The Has anyone dealt info in this thread is essential. Coming back to this for sure.

Last edited: Oct 31, 2024 at 11:54 PM
50 21CanadaChris, ZaraB_AL, JakeSmashed95 and 47 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Oct 31, 2024 at 6:11 PM#19

Clinical perspective on Has anyone dealt with mash resolution:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

11 9LindaRN_retired, tommy_boulder, hyun_seoul and 8 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Oct 31, 2024 at 6:28 PM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

43 15tyler_CSCS, VanRx_Mike, steve_okc and 40 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register